
ICUI · NASDAQ
ICU Medical, Inc.
$173.80 +0.96 (+0.56%)
Company overview
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD antimicrobial barrier caps for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as the Diana hazardous drug compounding system for preparing hazardous drugs.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $4.3B
- Employees
- 15,000
- Headquarters
- San Clemente, CA
- Website
- icumed.com
- CEO
- Vivek Jain
- Listed
- March 31, 1992
- P/E
- 92.94
- Dividend yield
- 0.00%
Company financials
- Revenue
- $2.2B
- Gross profit
- $784M
- Operating income
- $80.2M
- EBITDA
- $314M
- Net income
- $46.3M
- EPS
- $1.87
- Total assets
- $4B
- Total debt
- $1.3B
- Gross margin
- 36.36%
- Net margin
- 2.15%
- Earnings yield
- 1.08%
Showing FY 2025
News